KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hologic (HOLX) Research & Development (2016 - 2025)

Hologic's Research & Development history spans 17 years, with the latest figure at $60.5 million for Q4 2025.

  • For Q4 2025, Research & Development changed N/A year-over-year to $60.5 million; the TTM value through Dec 2025 reached $253.4 million, changed N/A, while the annual FY2024 figure was $272.8 million, 7.31% down from the prior year.
  • Research & Development for Q4 2025 was $60.5 million at Hologic, down from $61.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $76.0 million in Q3 2022 and bottomed at $60.5 million in Q4 2025.
  • The 5-year median for Research & Development is $71.0 million (2022), against an average of $69.5 million.
  • The largest annual shift saw Research & Development rose 11.52% in 2023 before it dropped 17.56% in 2025.
  • A 5-year view of Research & Development shows it stood at $72.8 million in 2021, then increased by 2.75% to $74.8 million in 2022, then decreased by 10.7% to $66.8 million in 2023, then increased by 0.75% to $67.3 million in 2024, then fell by 10.1% to $60.5 million in 2025.
  • Per Business Quant, the three most recent readings for HOLX's Research & Development are $60.5 million (Q4 2025), $61.5 million (Q1 2025), and $67.3 million (Q3 2024).